GERMANTOWN, Md., Nov. 8, 2010 /PRNewswire-USNewswire/ -- Sensors for Medicine and Science, Inc., a clinical-stage, medical device company pioneering breakthrough technology that could dramatically improve glucose monitoring for people with diabetes, today announced that Tim Goodnow, Ph.D., will be joining the Board of Directors and working with the Company as a Consultant.
Dr. Goodnow was most recently with Abbott Diabetes Care where he was the Vice President, Technical Operations. Prior to that, he held positions at TheraSense, Verax Biomedical, Dade Behring and Baxter Healthcare. Dr. Goodnow has led the successful development of a number of FDA approved glucose monitoring systems. He holds a Ph.D. and B.S. in Chemistry from the University of Miami.
“I am thrilled to be joining the Sensors for Medicine and Science Board of Directors,” said Dr. Goodnow. “I look forward to working with the team to successfully launch these innovative new devices and am excited about the improvements they can make for people with diabetes.”
“Tim is a great addition to our Board,” stated Stephen P. DeFalco, Executive Chairman. “His experience and track record bringing innovative glucose monitoring devices to market will help accelerate our efforts.”
Sensors for Medicine and Science’s lead product is a long-term, implanted continuous glucose monitor based on its unique and proprietary sensor technology. This product includes a miniaturized sensor and an external reader. The sensor is inductively powered and remotely interrogated, so there is no battery on-board and no wires connecting the implanted sensor to the external reader. As a result, after implantation, the sensor functions noninvasively, painlessly, automatically, and continuously. The Company is also developing a version of the technology to support efforts for glycemic control of patients in an Intensive Care Unit setting.
About Sensors for Medicine and Science, Inc.
Sensors for Medicine and Science, Inc. is pioneering breakthrough technology that could dramatically improve glucose monitoring for people with diabetes. The Company believes that its long-term, continuous glucose monitor technology has the potential to replace regular finger stick monitoring.
Sensors for Medicine and Science, Inc. has also developed oxygen sensor technology, with potential applications in areas such as metabolic monitoring (weight management), respiratory and cardiac disease. In addition, the Company sells its oxygen sensors as a component to original equipment manufacturers.
For more information about Sensors for Medicine and Science, Inc., please visit http://www.s4ms.com.
SOURCE Sensors for Medicine and Science, Inc.
